Sirion Raises $45 Million

Sirion Therapeutics Inc., a Tampa, Fla.-based drug company focused on ophthalmic products, has raised $45 million in Series B funding. Aisling Capital led the deal, and was joined by Investor Growth Capital, Atlas Venture, Advent International, Bear Sterns Healthcare Value Partners and Series A backer NovaQuest. www.siriontherapeutics.com